Brazilian HTA To Adopt Cost-Effectiveness Thresholds
Brazil’s health technology assessment institute is to incorporate cost-effectiveness thresholds into its decision making.
You may also be interested in...
Mexico aims to speed up the registration of generics and biosimilars.
New tendering rules in Belgium aim to improve competition between biosimilars and originators, for example by setting contract durations for tendering contracts and limiting the criteria for such contracts.
Important updates to good manufacturing practice guidelines are likely to mean medicine shortages, warns a German pharmaceutical industry group.